Cyclica spins out startup, Perturba Therapeutics, from the University of Toronto
A new biotech startup, Perturba Therapeutics Inc. was spun out of Cyclica’s AI-augmented chemistry technology and the University of Toronto Staljar Lab’s biological science, reports BetaKit.
